| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 13 |
| NetGPI | no | yes: 0, no: 13 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QD59
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 4 | 6 | PF00675 | 0.468 |
| CLV_PCSK_KEX2_1 | 4 | 6 | PF00082 | 0.468 |
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.498 |
| DEG_SPOP_SBC_1 | 37 | 41 | PF00917 | 0.487 |
| DOC_MAPK_DCC_7 | 30 | 38 | PF00069 | 0.509 |
| DOC_MAPK_MEF2A_6 | 30 | 38 | PF00069 | 0.488 |
| DOC_PP4_MxPP_1 | 31 | 34 | PF00568 | 0.591 |
| DOC_USP7_MATH_1 | 52 | 56 | PF00917 | 0.484 |
| DOC_WW_Pin1_4 | 21 | 26 | PF00397 | 0.487 |
| DOC_WW_Pin1_4 | 66 | 71 | PF00397 | 0.578 |
| DOC_WW_Pin1_4 | 77 | 82 | PF00397 | 0.550 |
| LIG_14-3-3_CanoR_1 | 19 | 25 | PF00244 | 0.479 |
| LIG_14-3-3_CanoR_1 | 4 | 13 | PF00244 | 0.425 |
| LIG_14-3-3_CanoR_1 | 96 | 105 | PF00244 | 0.432 |
| LIG_Actin_WH2_2 | 81 | 98 | PF00022 | 0.492 |
| LIG_FHA_1 | 102 | 108 | PF00498 | 0.369 |
| LIG_FHA_1 | 37 | 43 | PF00498 | 0.686 |
| LIG_FHA_1 | 78 | 84 | PF00498 | 0.523 |
| LIG_FHA_1 | 90 | 96 | PF00498 | 0.405 |
| LIG_LIR_Gen_1 | 104 | 113 | PF02991 | 0.449 |
| LIG_LIR_Gen_1 | 50 | 58 | PF02991 | 0.530 |
| LIG_LIR_Nem_3 | 104 | 108 | PF02991 | 0.432 |
| LIG_LIR_Nem_3 | 50 | 56 | PF02991 | 0.497 |
| LIG_MYND_1 | 33 | 37 | PF01753 | 0.626 |
| LIG_NRBOX | 72 | 78 | PF00104 | 0.576 |
| LIG_SH2_CRK | 105 | 109 | PF00017 | 0.437 |
| LIG_SH2_CRK | 17 | 21 | PF00017 | 0.441 |
| LIG_SH2_STAP1 | 105 | 109 | PF00017 | 0.462 |
| LIG_SH3_3 | 31 | 37 | PF00018 | 0.579 |
| LIG_SUMO_SIM_anti_2 | 106 | 111 | PF11976 | 0.499 |
| MOD_CK1_1 | 47 | 53 | PF00069 | 0.622 |
| MOD_Cter_Amidation | 2 | 5 | PF01082 | 0.543 |
| MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.611 |
| MOD_GSK3_1 | 38 | 45 | PF00069 | 0.530 |
| MOD_NEK2_1 | 20 | 25 | PF00069 | 0.408 |
| MOD_Plk_4 | 103 | 109 | PF00069 | 0.350 |
| MOD_Plk_4 | 52 | 58 | PF00069 | 0.634 |
| MOD_Plk_4 | 72 | 78 | PF00069 | 0.440 |
| MOD_Plk_4 | 89 | 95 | PF00069 | 0.477 |
| MOD_ProDKin_1 | 21 | 27 | PF00069 | 0.487 |
| MOD_ProDKin_1 | 66 | 72 | PF00069 | 0.572 |
| MOD_ProDKin_1 | 77 | 83 | PF00069 | 0.550 |
| TRG_ENDOCYTIC_2 | 105 | 108 | PF00928 | 0.405 |
| TRG_ENDOCYTIC_2 | 17 | 20 | PF00928 | 0.409 |
| TRG_ER_diArg_1 | 4 | 6 | PF00400 | 0.468 |
| TRG_Pf-PMV_PEXEL_1 | 96 | 100 | PF00026 | 0.391 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1I123 | Leptomonas seymouri | 71% | 100% |
| A0A0S4IR74 | Bodo saltans | 33% | 70% |
| A0A0S4KIC6 | Bodo saltans | 42% | 100% |
| A0A1X0P673 | Trypanosomatidae | 53% | 100% |
| A0A1X0P697 | Trypanosomatidae | 40% | 91% |
| A0A3Q8IBH0 | Leishmania donovani | 38% | 93% |
| A0A3Q8IBJ2 | Leishmania donovani | 97% | 100% |
| A0A422NUP2 | Trypanosoma rangeli | 49% | 100% |
| A4HA99 | Leishmania braziliensis | 83% | 100% |
| A4HYH9 | Leishmania infantum | 97% | 100% |
| D0A0V3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 91% |
| E9ASA3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |